Medical Review

Current status, as of September 27, 2026: no clinician reviewer is appointed, and no page on this site carries a clinician review. What follows is the standard we will apply once a reviewer is in place, not a description of what happens today.

What medical review means here

Medical review means a check performed by a licensed clinician before a page is published. It is separate from editing. Our editor checks structure, sourcing, and readability. A reviewer, once appointed, will check whether the clinical content is accurate and safely framed.

Articles on this site are drafted with AI assistance. A human editor revises the draft, verifies each claim against a cited source, and rewrites as needed. That editing step happens on every page today. The clinician step does not, because there is no reviewer to perform it. Nothing is published straight from an AI tool.

Which pages will be reviewed

  • Pages describing what ivermectin is, how it works, and its approved uses.
  • Pages covering dosing, side effects, drug interactions, contraindications, or overdose.
  • Pages about veterinary ivermectin products and the risks of human use.
  • Pages describing FDA status, prescription requirements, or off-label use.

Pages that contain no clinical content — for example, site policies, our correction log, and this page — are edited but will not be medically reviewed. They will not carry a reviewer byline.

What the reviewer will check

  • Factual accuracy. Every clinical statement will be checked against current labeling and published literature. Statements that cannot be supported are cut or rewritten.
  • Safety framing. Risks, warnings, and "when to call a doctor" guidance must be present and prominent, not buried at the end.
  • No treatment claims. The site must not state or imply that ivermectin treats conditions for which it is not approved and for which evidence does not support use.
  • Correct regulatory status. Approved indications, prescription-only status, and the distinction between human and veterinary formulations must be stated accurately.
  • Separation of commerce and clinical content. Purchasing information must not be presented as a clinical recommendation.

The reviewer can require changes, and can refuse to sign off. If a reviewer refuses, the page is not published with a reviewer byline. It is either rewritten or removed.

What the reviewer does not do

  • They do not give medical advice to readers. They do not answer individual health questions submitted through this site.
  • They do not have a clinician-patient relationship with anyone who reads the site.
  • They do not endorse, recommend, or vet any pharmacy, seller, product, or price listed here.
  • They do not write the articles. Review is a separate step from drafting.

Re-review schedule

Reviewed pages will be re-checked at least once every 12 months. A page will be pulled forward for earlier re-review when any of the following happens: FDA labeling changes, a new safety communication is issued, a reader reports an error, or the editor makes a substantive change to clinical content. Minor fixes — typos, formatting, broken links — will not trigger re-review. Once clinician review begins, a reviewed page will show the date of the most recent clinician sign-off alongside the reviewer's name. Today the "last reviewed" date on every page is the date of the most recent editor check, as described in our editorial policy.

Our reviewers

No clinician reviewer is appointed at this time, so there is no one to list here. When a reviewer is appointed, this page will name them and give their credential, current role, state of licensure and license number, areas of focus, and a link to a verifiable professional profile.

Clinicians: how to apply

We are looking to work with licensed physicians, pharmacists, and nurse practitioners in good standing. To be considered, email info@ivermectinreport.com with your full name, credential, state of licensure and license number, and a link to a verifiable professional profile. We will verify licensure through the relevant state board before any reviewer byline appears on the site. Reviewers will be paid a flat fee per page and will be told in writing that they may require changes or decline to sign off.